| In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent. | |
| | |
MedLine Citation:
|
PMID: 15757605 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Between April 2002 and May 2004, 174 consecutive patients who underwent percutaneous coronary intervention of bifurcational lesions with sirolimus-eluting stents were identified. Two strategies were used: stenting only 1 branch (group 1S, n = 57) or stenting both branches (group 2S, n = 117). The incidence of major adverse cardiac events was evaluated in the hospital and at 9-month follow-up. There were no statistically significant differences between the 2 groups with regard to the incidence of target lesion revascularization (5.4% vs 8.9%, p = 0.76), target vessel revascularization (5.4% vs 11.1%, p = 0.51), and cumulative major adverse cardiac events (18.9% vs 23.3%, p = 0.76) at 9 months. |
| | |
Authors:
|
Lei Ge; Eleutheria Tsagalou; Ioannis Iakovou; Giuseppe M Sangiorgi; Nicola Corvaja; Flavio Airoldi; Alaide Chieffo; Matteo Montorfano; Iassen Michev; Antonio Colombo |
Related Documents
:
|
10636365 - Outcomes at 1 year and economic implications of platelet glycoprotein iib/iiia blockade... 14662245 - A randomized trial comparing primary infarct artery stenting with or without abciximab ... 20603505 - Lesion characteristics and coronary stent selection with computed tomographic coronary ... 14715195 - Severe ostial saphenous vein graft disease leading to acute coronary syndromes followin... 3121335 - Residual coronary stenosis after thrombolysis with rt-pa or streptokinase: acute result... 21289945 - The role of homocysteine as a predictor for coronary heart disease. |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: The American journal of cardiology Volume: 95 ISSN: 0002-9149 ISO Abbreviation: Am. J. Cardiol. Publication Date: 2005 Mar |
Date Detail:
|
Created Date: 2005-03-10 Completed Date: 2005-04-21 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0207277 Medline TA: Am J Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 757-60 Citation Subset: AIM; IM |
Affiliation:
|
EMO Centro Cuore Columbus and San Raffaele Hospital, Milan, Italy; Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Angina, Unstable / mortality, therapy* Angioplasty, Transluminal, Percutaneous Coronary / methods* Coronary Angiography Coronary Artery Disease / mortality, therapy* Coronary Restenosis / mortality Death, Sudden, Cardiac / epidemiology Female Follow-Up Studies Hospital Mortality* Humans Male Middle Aged Myocardial Infarction / mortality, therapy Outcome and Process Assessment (Health Care) Risk Factors Sirolimus / adverse effects* Stents* |
| Chemical | |
Reg. No./Substance:
|
53123-88-9/Sirolimus |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Risks of noncardiac surgery after coronary stenting.
Next Document: Quality of life in octagenarians after coronary artery bypass grafting.